Cosmetic Camouflage Benefits Youth With Visible Skin Issues

This article originally appeared here.
Share this content:
Cosmetic Camouflage Benefits Youth With Visible Skin Issues
Cosmetic Camouflage Benefits Youth With Visible Skin Issues

FRIDAY, Oct. 31, 2014 (HealthDay News) -- Cosmetic camouflage can improve quality of life in children and adolescents with visible vascular and pigmentary anomalies, according to a study published in the November issue of the Journal of the American Academy of Dermatology.

Michele L. Ramien, M.D., from the University of Montreal, and colleagues examined the effect of visible skin anomalies and their camouflage on quality of life. Data were included for 41 children and adolescents aged 5 years and older who were taught to use cosmetic camouflage. The Children's Dermatology Life Quality Index (CDLQI) was used to assess quality of life before and six months after the intervention.

The researchers found that baseline quality of life scores demonstrated a small and small to moderate impact of vascular anomalies and pigmentary anomalies, respectively (CDLQI score 4.2 and 6.1, respectively). There was improvement in quality of life in the whole study population six months after the intervention (CDLQI score 5.1 versus 2.1), with significant improvements for facial lesions and vascular malformations. Cosmetic camouflage was well tolerated, and the likelihood of continuing with these products was higher for patients with pigmentary anomalies.

"Children and teenagers with visible vascular and pigmentary anomalies experience an impairment of quality of life that is abrogated by introduction to use of cosmetic camouflage," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »